DR. PHILLIP JAY GLASGOW M.D. NPI 1306230586

NPI Details

DR. Phillip Jay Glasgow, M.D. is a family medicine in Texarkana, AR with 10 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Phillip Jay Glasgow, M.D. NPI is 1306230586. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

300 E 6TH ST
TEXARKANA, AR
ZIP 71854-207
Phone: (870) 779-6000
Fax: (870) 779-6093

The NPI 1306230586 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• X-ray of chest, 2 views (HCPCS:71046)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Urinalysis, manual test (HCPCS:81002)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Blood glucose (sugar) level (HCPCS:82947)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Professional service for single injection of allergen (HCPCS:95115)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• X-ray of chest, 1 view (HCPCS:71045)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• X-ray of knee, 3 views (HCPCS:73562)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Emergency department visit for life threatening or functioning severity (HCPCS:99285)
• Removal of impacted ear wax (HCPCS:69210)
• Red blood cell concentration measurement (HCPCS:85014)
• Blood count, hemoglobin (HCPCS:85018)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Photography of the retina (HCPCS:92250)
• Test for detection of infectious agent antibody, qualitative or semiquantitative (HCPCS:86318)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)

The enumeration date for this NPI number is 3/25/2015 and was last updated on 11/15/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: